(1)
Haidar Mohammed Hussein; Ali Abdulhussein Kasim. Correlation of the Complement Decay Accelerating Factor, Tumour Necrosis Factors-Alpha, and Interleukin-1 Beta With the Response to Rituximab in Rheumatoid Arthritis Patients. Iraqi Journal of Pharmaceutical Sciences 2025, 33 (4SI), 222-229. https://doi.org/10.31351/vol33iss(4SI)pp222-229.